Rapibloc Phebra Pty Ltd
Product name
Rapibloc
Sponsor
Accepted date
Oct-2024
Active ingredients
landiolol hydrochloride
Proposed indication
For the acute treatment of elevated heart rate and irregular heartbeat (arrhythmia).
Application type
A (new medicine)
Publication date
Oct-2024